- Home
- CLPT
as 10-17-2025 3:45pm EST
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 742.2M | IPO Year: | N/A |
| Target Price: | $27.67 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.76 - $30.10 | Next Earning Date: | 11-06-2025 |
| Revenue: | $33,593,000 | Revenue Growth: | 19.68% |
| Revenue Growth (this year): | 22.34% | Revenue Growth (next year): | 25.50% |
Stock Insider Trading Activity of ClearPoint Neuro Inc. (CLPT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH MICHAEL | CLPT | CEO and President | Oct 10 '25 | Sell | $28.00 | 26,463 | $714,020.53 | 225,939 |
Latest ClearPoint Neuro Inc. News
CLPT Breaking Stock News: Dive into CLPT Ticker-Specific Updates for Smart Investing
ACCESS Newswire
11 days ago
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
ACCESS Newswire
12 days ago
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
Zacks
13 days ago
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
Simply Wall St.
15 days ago
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress
ACCESS Newswire
17 days ago
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
Insider Monkey
4 months ago
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
TipRanks
4 months ago
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
Simply Wall St.
5 months ago
ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Compare CLPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLPT ClearPoint Neuro Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.